ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio Streamlining Data Management and Review

Leveraging the Power of AI in Clinical Trials

The adoption of Medidata Clinical Data Studio by ICON plc marks a significant milestone in the integration of artificial intelligence (AI) in clinical trials. By harnessing the power of AI, ICON aims to streamline its clinical research operations, enhance data quality, and accelerate the pace of innovation in the life sciences industry.

Medidata is a leading provider of clinical trial management systems, offering a comprehensive suite of tools and services to support the entire clinical trial lifecycle.

*Enhanced trial efficiency*: Medidata’s platform streamlines clinical trial operations, reducing the time and cost associated with trial management.

*Improved data quality*: Medidata’s analytics-powered insights and data validation tools ensure that clinical trial data is accurate, reliable, and compliant with regulatory requirements.

*Increased patient engagement*: Medidata’s patient engagement platform enables patients to participate in clinical trials, providing them with valuable insights into their treatment options and improving their overall experience.Industry-Leading Expertise

Medidata’s industry-leading expertise is built on a deep understanding of the clinical trial landscape.

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. 370,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations.

Further details on this topic will be provided shortly.